Researchers from the Princess Máxima Center, the Netherlands Cancer Institute, and Oncode Institute have unearthed valuable knowledge about the origin of rhabdoid tumors, an aggressive form of cancer diagnosed in children, through studying mini, lab-grown tumors. Their research has managed to identify a potential target for future therapies. Utrecht,...
Latest News
COPENHAGEN – A grant from the Novo Nordisk Foundation of up to 300 million euros now enables the establishment of a major international research center focused on stem cell medicine. The center will be a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands. The partnership...
PHILADELPHIA – New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN, led the study which looked...
CHICAGO – The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is excited to share that a new article focused on sarcoidosis has been published by the New England Journal of Medicine (NEJM), the most...
Gov. M. Jodi Rell has signed legislation that will require health insurers to cover wound-care supplies for treatment of epidermolysis bullosa (EB), a rare genetic skin disease that causes blisters to develop easily from the slightest pressure. The bill takes effect Jan. 1, 2010. About 50 people in Connecticut have...
DUBLIN – Horizon Therapeutics plc (Nasdaq: HZNP) today announced new UPLIZNA (inebilizumab-cdon) data being presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually April 17-22, 2021 (AAN 2021), including new, end-of-study data from the open-label extension period of the pivotal N-MOmentum trial in patients with NMOSD. UPLIZNA is the first and...
Researchers based in Gabon and France report the discovery of a new malaria agent infecting chimpanzees in Central Africa. This new species, named Plasmodium gaboni, is a close relative of the most virulent human agent P. falciparum; it is described in an article published May 29 in the open-access journal...
SCOTTSDALE, Ariz. — MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report entitled “Thought Leader Insight & Analysis: Alzheimer’s Disease,” designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments...
Using a new technology for inserting large DNA sections into a genome, scientists have successfully created a mouse model of Parkinson’s disease that has the same impairments of movement and degenerative brain changes as the human disease, according to a study published online June 7 in Nature Neuroscience. Yanping Li,...
Sydney, Australia – An international research team has discovered a new way to effectively treat cancer, by using nutrients to reactivate suppressed metabolic pathways in cancer cells. The researchers used a common amino acid, tyrosine, packaged as a nanomedicine, to change the metabolism of melanoma, a deadly skin cancer, and...